OXYCODONE HYDROCHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for oxycodone hydrochloride and what is the scope of patent protection?
Oxycodone hydrochloride
is the generic ingredient in five branded drugs marketed by Ani Pharms, Avanthi Inc, Dr Reddys Labs Sa, Genus Lifesciences, Lannett Co Inc, Novel Labs Inc, Abhai Llc, Alkem Labs Ltd, Ascent Pharms Inc, Aurolife Pharma Llc, Chartwell Molecular, Hikma, Pharm Assoc, Quagen, Rhodes Pharms, Specgx Llc, Vistapharm, Vistapharm Llc, Wes Pharma Inc, Xttrium Labs Inc, Purdue Pharma Lp, Roxane, Zyla, Actavis Elizabeth, Alvogen, Amneal Pharms, Epic Pharma Llc, Nesher Pharms, Nuvo Pharm, Strides Pharma, Sun Pharm Inds Inc, and Protega Pharms, and is included in fifty-two NDAs. There are twenty-one patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.Oxycodone hydrochloride has four hundred and eight patent family members in forty-eight countries.
There are twelve drug master file entries for oxycodone hydrochloride. Forty-four suppliers are listed for this compound. There are four tentative approvals for this compound.
Summary for OXYCODONE HYDROCHLORIDE
International Patents: | 408 |
US Patents: | 21 |
Tradenames: | 5 |
Applicants: | 32 |
NDAs: | 52 |
Drug Master File Entries: | 12 |
Finished Product Suppliers / Packagers: | 44 |
Raw Ingredient (Bulk) Api Vendors: | 28 |
Clinical Trials: | 575 |
Patent Applications: | 3,105 |
Formulation / Manufacturing: | see details |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for OXYCODONE HYDROCHLORIDE |
What excipients (inactive ingredients) are in OXYCODONE HYDROCHLORIDE? | OXYCODONE HYDROCHLORIDE excipients list |
DailyMed Link: | OXYCODONE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for OXYCODONE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Henry Ford Health System | Phase 4 |
University of Miami | Phase 3 |
Murdoch Childrens Research Institute | Phase 4 |
Generic filers with tentative approvals for OXYCODONE HYDROCHLORIDE
Applicant | Application No. | Strength | Dosage Form |
⤷ Sign Up | ⤷ Sign Up | 80MG | TABLET, EXTENDED RELEASE; ORAL |
⤷ Sign Up | ⤷ Sign Up | 80MG | TABLET, EXTENDED RELEASE; ORAL |
⤷ Sign Up | ⤷ Sign Up | 40MG | TABLET, EXTENDED RELEASE; ORAL |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Pharmacology for OXYCODONE HYDROCHLORIDE
Drug Class | Opioid Agonist |
Mechanism of Action | Full Opioid Agonists |
Anatomical Therapeutic Chemical (ATC) Classes for OXYCODONE HYDROCHLORIDE
Paragraph IV (Patent) Challenges for OXYCODONE HYDROCHLORIDE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
OXAYDO | Tablets | oxycodone hydrochloride | 5 mg and 7.5 mg | 202080 | 1 | 2012-02-07 |
OXYCONTIN | Extended-release Tablets | oxycodone hydrochloride | 20 mg | 022272 | 2 | 2010-10-29 |
OXYCONTIN | Extended-release Tablets | oxycodone hydrochloride | 15 mg | 022272 | 1 | 2010-10-28 |
OXYCONTIN | Extended-release Tablets | oxycodone hydrochloride | 10 mg | 022272 | 1 | 2010-10-25 |
OXYCONTIN | Extended-release Tablets | oxycodone hydrochloride | 30 mg, 60 mg and 80 mg | 022272 | 1 | 2010-10-18 |
OXYCONTIN | Extended-release Tablets | oxycodone hydrochloride | 40 mg | 022272 | 1 | 2010-10-04 |
US Patents and Regulatory Information for OXYCODONE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-005 | Apr 5, 2010 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Specgx Llc | ROXICODONE | oxycodone hydrochloride | TABLET;ORAL | 021011-001 | Aug 31, 2000 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-002 | Apr 5, 2010 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-006 | Apr 5, 2010 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Epic Pharma Llc | OXYCODONE HYDROCHLORIDE | oxycodone hydrochloride | TABLET;ORAL | 090895-001 | Aug 24, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for OXYCODONE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-001 | Apr 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-006 | Apr 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-005 | Apr 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-007 | Apr 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
Purdue Pharma Lp | OXYCONTIN | oxycodone hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 022272-005 | Apr 5, 2010 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for OXYCODONE HYDROCHLORIDE
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 2082742 | Formes de dosage pharmaceutiques orales anti-manipulation contenant un analgésique opioide (Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic) | ⤷ Sign Up |
Spain | 2566363 | ⤷ Sign Up | |
Brazil | PI0508758 | processo para a preparação de cloridrato de oxicodona tendo menos que 25 ppm de 14 - hidroxicodeinona | ⤷ Sign Up |
Hungary | E028233 | ⤷ Sign Up | |
Austria | E499101 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for OXYCODONE HYDROCHLORIDE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1685839 | 92292 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.